Changes in the expression of CD64/FcγRI, CD80, CD86, and CXCR2 were further analyzed in a validation experiment using peripheral blood monocytes from 20 patients with RA and 8 controls (Fig. 1). This evidence concerns the gene CD80 and rheumatoid arthritis.